Clinical Trials Directory

Trials / Completed

CompletedNCT01738399

Coffee and Metabolic Health Outcomes

Influence of Coffee Consumption on Insulin Sensitivity in Overweight and Insulin Resistant Subjects.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
128 (actual)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
35 Years – 69 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to investigate the long-term (24 weeks) effects of coffee consumption on insulin sensitivity in insulin resistant individuals.

Detailed description

Coffee is a major source of the phenolic acid chlorogenic acid and a substantial source of trigonelline, niacin, lignans magnesium, and potassium. Several of these compounds have been shown to improve glucose metabolism in animal models. Consumption of coffee was inversely associated with the risk of type-2 diabetes in prospective cohort studies across the world. Consumption of 3 to 4 cups of coffee per day was associated with an approximately 25% lower risk of type-2 diabetes. However, direct evidence of the efficacy of coffee to reduce blood glucose and insulin resistance parameters in humans from randomized trials is still lacking. In recent small trials of short duration (up to 6 weeks) coffee consumption increased levels of the insulin-sensitizing hormone adiponectin, but did not significantly improve insulin sensitivity These results suggest that a larger longer-term trial of the effects of coffee consumption on directly measured insulin sensitivity is warranted.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCoffee
DIETARY_SUPPLEMENTPlacebo

Timeline

Start date
2012-04-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2012-11-30
Last updated
2015-04-23

Locations

2 sites across 1 country: Singapore

Source: ClinicalTrials.gov record NCT01738399. Inclusion in this directory is not an endorsement.